Monthly Archives: February 2022

2021 developments on the issue of the governing law of the arbitration agreement in the UK

Continuing our review of key arbitration developments from 2021 (see Bernhard Maier’s briefing here on mining treaty disputes), Neil Newing looks at the UK Supreme Court (“UKSC”) decision of Kabab-Ji SAL v Kout Food Group here – the second case within the space of a year in which the Supreme Court looked at the issue of the governing law of the arbitration agreement.

Feb 28, 2022

Key developments in mining disputes

Our team at Signature has started the year with a brainstorming session on key developments from 2021 that we wish to share with you to start the conversation on #InternationalArbitration, on LinkedIn.

Feb 27, 2022

HP gets a ‘dog-leg’ up from FSMA in successful fraud claims against Autonomy founder

Senior Associate Alasdair Glass discusses the recent successful HP fraud claims against Autonomy founder Mike Lynch and the implications this may have for the sector.

Feb 24, 2022

Partner Sylvie Gallage-Alwis discusses developments in anti-waste regulations in France

Partner Sylvie Gallage-Alwis discusses developments in anti-waste regulations in France since first introduced, what companies should be aware of in the coming years and what further developments we can expect to see in 2022.

Feb 21, 2022

Partner Sylvie Gallage-Alwis comments in the Financial Times on the rise on greenwashing litigation

Partner Sylvie Gallage-Alwis comments in the Financial Times on the rise of greenwashing litigation and cases relating to companies’ sustainability claims.

Feb 18, 2022

Signature Litigation ranked in Chambers Global 2022 Guide

Signature Litigation and its members across all offices have been ranked again in the Chambers Global Guide across several practice areas.

Feb 17, 2022

Partner Elliott Phillips and Associate Paul Grant discuss the Valereum takeover of GSX

Partner Elliott Phillips and Associate Paul Grant discuss the move from blockchain company Valereum to purchase a 90% stake in the Gibraltar Stock Exchange and create the world’s first integrated bourse, in Global Investor.

Feb 15, 2022

Partner Thomas Rouhette comments in report examining the role of litigation PR in an evolving dispute ecosystem

Partner Thomas Rouhette provides his perspective on the use of litigation PR in France, which has been seen in recent years as a plaintiff friendly jurisdiction.

Feb 11, 2022

Counsel Kate Gee examines the steps the UK legal system is taking to keep up with advances in technology

Kate Gee discusses whether the legal system can keep up with crypto and AI

Feb 07, 2022

Counsel Kate Gee discusses developments to the litigation funding market in Edward Fennell’s Legal Diary

Kate Gee discusses developments to the litigation funding and disputes market and whether further regulation will deter the advance of third party funding.

Feb 04, 2022

Partner Sylvie Gallage-Alwis discusses the latest FIVA report and asbestos litigation, in ODA

Sylvie Gallage-Alwis examines the latest trends is asbestos litigations and what the latest FIVA report indicates for the future of asbestos litigation.

Feb 03, 2022

Neil Newing and Alasdair Marshall discuss the reform of the Arbitration Act 1996 in The Law Society Gazette

Counsel Neil Newing and Associate Alasdair Marshall discuss the reform of the Arbitration Act 1996 in The Law Society Gazette.

Feb 03, 2022

Counsel Kate Gee discusses whether the UK legal system needs to bridge the gap between emerging technologies in Global Risk Regulator

Kate Gee discusses whether the UK legal system needs to integrate technology to retain remain a leading centre of litigation, in Global Risk Regulator.

Feb 03, 2022

Emmanuèle Lutfalla comments in relation to a French court’s decision regarding backing a class action against French multinational healthcare company Sanofi

Partner Emmanuèle Lutfalla comments on the insurance consequences in relation to a French court’s recent decision regarding backing a class action against French multinational healthcare company Sanofi in the so-called Depakine case.

Feb 02, 2022